Skip to main content

Priority-driven Collaborative Cancer Research Scheme

A A

Cancer Australia has established the Priority-driven Collaborative Cancer Research Scheme to support research that reduces the impact of cancer on the community and improves outcomes for people affected by cancer.

Overview

The Priority-driven Collaborative Cancer Research Scheme is an innovative annual national research project grants funding scheme which brings together government and other funders to collaboratively fund cancer research in Australia.

This funding scheme helps to:

  • coordinate funding of priority-driven cancer research at the national level,
  • foster collaboration between cancer researchers to build Australia’s cancer research capacity, and
  • foster consumer participation in cancer research, from design to implementation.

Working with the National Health and Medical Research Council (NHMRC)

This research scheme is managed by Cancer Australia and the agency collaborates with the NHMRC in this grant scheme. The NHMRC facilitates registration and initial assessment of applications, and endorses grants funded through this scheme in recognition of their scientific merit.

Successful applicants for 2020 Round

Cancer Australia, Australian Lions Childhood Cancer Research Foundation, Cure Cancer, Leukaemia Foundation, My Room, National Breast Cancer Foundation, and The Kids’ Cancer Project, are pleased to announce the successful applicants to the 2020 Round of the Priority-driven Collaborative Cancer Research Scheme.

Beatty, Lisa
Flinders University
Finding My Way-Advanced: Can a web-based psychosocial intervention improve mental quality of life for women with metastatic breast cancer?
Funded by: Cancer Australia

Beavis, Paul
Peter MacCallum Cancer Centre, University of Melbourne
Augmenting CXCR3 ligand production to enhance the trafficking of T cells in solid cancers
Co-funded by: Cancer Australia and National Breast Cancer Foundation

Best, Sarah
The Walter and Eliza Hall Institute of Medical Research
Designing personalised treatment strategies for KEAP1-mutant lung cancer
Funded by: Cancer Australia

Brown, Michael
Royal Adelaide Hospital, Central Adelaide Local Health Network
A new gene modification strategy for generating optimised CAR-T cells for therapy of glioblastoma
Funded by: Cancer Australia

Buck, Jessica
Telethon Kids Institute, University of Western Australia
Exploiting and enhancing brain-resident immune cells for the treatment of paediatric brainstem glioma (DIPG)
Co-funded by: Australian Lions Childhood Cancer Research Foundation and My Room

Call, Matthew
The Walter and Eliza Hall Institute of Medical Research
Improving safety and efficacy of chimeric antigen receptor (CAR)-T cell therapies
Funded by: Cancer Australia

Faridi, Pouya
Monash University
Novel targets for paediatric brain tumour immunotherapy
Co-funded by: Cancer Australia, Australian Lions Childhood Cancer Research Foundation, and My Room

Faulkner, Geoffrey
Mater Research Institute, The University of Queensland
Long-read genetic and epigenetic profiling in lung cancer for precision medicine
Funded by: Cancer Australia

Gordon, Louisa
QIMR Berghofer, The Council of the Queensland Institute of Medical Research
The harms and benefits of sun exposure: striking the right balance
Funded by: Cancer Australia

Gorringe, Kylie
Peter MacCallum Cancer Centre, University of Melbourne
A combined immuno-molecular biomarker for early breast disease
Co-funded by: Cancer Australia and National Breast Cancer Foundation

He, Bo
Harry Perkins Institute of Medical Research, The University of Western Australia
Reprogramming the tumour microenvironment to improve immunotherapy
Funded by: Cancer Australia

Li, Shuai
University of Melbourne
Comprehensively identifying causal risk factors for breast cancer with applications of contemporary causation assessment methods to inform prevention and risk prediction
Funded by: Cancer Australia

Nakamura, Kyohei
QIMR Berghofer, The Council of the Queensland Institute of Medical Research
Overcoming immunosuppression in B-cell lymphoma
Funded by: Leukaemia Foundation

Selth, Luke
Flinders University
Targeting CDK9 in lethal prostate cancer
Funded by: Cancer Australia

Vandyke, Kate
University of Adelaide
CCR1 as a key therapeutic target in the prevention of drug resistance and relapse in multiple myeloma
Co-funded by: Cancer Australia and Cure Cancer

Wardill, Hannah
University of Adelaide
Developing first translational model of paediatric GvHD to evaluate prophylactic efficacy of faecal microbiota transplantation
Funded by: Leukaemia Foundation

Cancer Australia's funding partners and successful applicants each PdCCRS round.

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

Find out more about: